Institutional investors purchased a net $2.2 million shares of NNVC during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 8.79% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.3 Million shares of NanoViricides Inc
SSGA FUNDS MANAGEMENT, INC. Bought 352.7 Thousand shares of NanoViricides Inc